HealthDay - MONDAY, Jan. 10 (HealthDay News) -- Fentanyl (Abstral) tablets have been approved by the U.S. Food and Drug Administration to help opioid-tolerant adults with cancer manage so-called "breakthrough" pain that occurs suddenly and requires a short-term higher dose of a patient's round-the-clock opioid regimen.
More...
More...